James P. Allison Institute
As the oncology world focuses its attention on the American Society of Clinical Oncology Annual Meeting, MD Anderson’s experts are sharing their pacesetting research that will change the clinic. From cutting-edge immunotherapies and targeted therapies to advanced surgical and radiation therapy techniques, our experts are leading the way to end cancer.
Below are highlights from our presentations, details about onsite networking opportunities with our experts and information on open trainee and faculty positions at MD Anderson.
MD Anderson researchers present encouraging results of early-stage clinical trials at 2022 ASCO Annual Meeting
Results from three early-stage clinical trials led by MD Anderson show promising activity with novel immunotherapies and targeted therapies for patients with advanced tumors
with chemoimmunotherapy improved progression-free survival for
newly diagnosed mantle cell lymphoma patients
Combination chemoimmunotherapy with the Bruton’s tyrosine kinase inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for previously untreated mantle cell lymphoma in patients 65 and over.
Studies reveal new insights into gut microbiome impact on immunotherapy response in multiple cancers, including glioblastoma
Two studies led by MD Anderson shed new light on the potential of the gut microbiome as a targetable biomarker to improve responses to immunotherapy
Meet the Experts
Visit booth 6122 to ask a question, learn about training and career opportunities and continue the conversation on key presentations with our experts.
Saturday, June 4
Sunday, June 5
James P. Allison Institute
The James P. Allison Institute is dedicated to advancing exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health. The institute builds upon the legacy of its namesake, James P. Allison, Ph.D., who was awarded the 2018 Nobel Prize in Physiology or Medicine for his fundamental discoveries in T cell biology and his invention of ipilimumab, the first immune checkpoint inhibitor to treat cancer.
Meet Dr. James Allison, Dr. Padmanee Sharma and Dr. Raghu Kalluri at the ASCO Annual Meeting on Monday, June 6 from 2-3 p.m. at booth 6122.
Education and Training at MD Anderson
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
Moon Shots Program
MD Anderson’s Moon Shots Program® aims to rapidly and dramatically improve cancer survival rates and reduce suffering through early detection, research and new treatments.Learn more